Coronary Interventions

View from the Thoraxcenter: EuroPCR 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Grigoris Karamasis , Iosif Xenogiannis , Charalampos Varlamos , et al

ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial

Bon-Kwon Koo,

ACC 22: FAME 3 Suggests CABG Outperforms FFR-Guided PCI in Patients with Multivessel Disease

Frederik Zimmermann,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

James Spratt, Adrian P Banning, Jonathan Hill, et al

AutocathFFR System Outcomes Comparable to Wire-Based FFR

Hector M Garcia-Garcia,

USC Discussion: Hemodynamics in Cardiogenic Shock

Alexander G Truesdell, Jaime A Hernandez-Montfort, Varinder Kaur Randhawa, et al

UZ Clear Finds 50% Patients with Angina Have Evidence of CAD

Carlos Collet,

José M de la Torre Hernández, Tamara García Camarero, Aritz Gil Ongay, et al

Ep 4: The EXCEL Trial: The Interventionalists’ Perspective

George William Hunter,

, Adriano Caixeta , Gregg Stone ,

Colin Berry ,

Dae-Hyun Lee , José M de la Torre Hernández ,

Remo Albiero ,

Georgia Tsoumakidou , Elias Brountzos ,

Michael Tittelbach , Tobias Diener ,

Fernando Alfonso ,

Kamal Chitkara , Anthony H Gershlick ,

Rajiv Rampat , David Hildick-Smith ,

Georgios J Vlachojannis , Bimmer E Claessen , George D Dangas ,

John Rawlins , Jehangir Din , Suneel Talwar , et al

Georg Nickenig, Todd Villines, Christopher P Cannon, et al

Videos

Nicolas M Van Mieghem, Joost Daemen,

View from the Thoraxcenter: EuroPCR 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Jonathan Hill, James Spratt, Charalambos Antoniades, et al

ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial

Bon-Kwon Koo,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

James Spratt, Adrian P Banning, Jonathan Hill, et al

Transcatheter Interventions Online 2022 - On Demand

Nicolas M Van Mieghem, Roxana Mehran, Lars Søndergaard, et al

USC Discussion: Hemodynamics in Cardiogenic Shock

Alexander G Truesdell, Jaime A Hernandez-Montfort, Varinder Kaur Randhawa, et al

UZ Clear Finds 50% Patients with Angina Have Evidence of CAD

Carlos Collet,

Bruno Scheller, Stefan Tunev, Darren Mylotte, et al

José M de la Torre Hernández, Tamara García Camarero, Aritz Gil Ongay, et al

Ep 4: The EXCEL Trial: The Interventionalists’ Perspective

George William Hunter,

PARTNER 3: TAVR is Cost Effective Compared with SAVR for Low-Risk Patients

David J Cohen,

View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

View from the Thoraxcenter: AHA 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

TCT 21: SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB

Bruno Scheller,

TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients

Susheel Kodali,

SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB

Rafael Romaguera,

iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR

Matthias Gotberg,

FAME3: PCI Guided by FFR Didn't Meet Noninferiority for 1Y Outcomes Compared to CABG

William Fearon,

View from the Thoraxcenter: TCT 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

Prognostication of patients with coronary stenoses: pre-and post-PCI

Andreas Seitz, Peter Ong,

Barbara Stähli , Stephan Kische, Tommaso Gori, et al

James Spratt, Holger Thiele, Joost Daemen, et al

RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

Nick Curzen,

Network Meta-Analysis on Target Lesion Failure with Current Drug-Eluting Stents

Tullio Palmerini,

View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

Cardio-oncology Discussion: Primary PCI in Cancer Patients

Arjun K Ghosh, Deepak L Bhatt, Cezar Iliescu, et al

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas,

Videos

Nicolas M Van Mieghem, Joost Daemen,

View from the Thoraxcenter: EuroPCR 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Innovations in Treating Complex PCI: The Role of Orbital Atherectomy

Nicolas M Van Mieghem, Kambis Mashayekhi, Amir Kaki, et al

Jonathan Hill, James Spratt, Charalambos Antoniades, et al

ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial

Bon-Kwon Koo,

ACC 22: FAME 3 Suggests CABG Outperforms FFR-Guided PCI in Patients with Multivessel Disease

Frederik Zimmermann,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Series Thumbnail

Carlos Collet, Jonathon A Leipsic,

James Spratt, Adrian P Banning, Jonathan Hill, et al

Transcatheter Interventions Online 2022 - On Demand

Nicolas M Van Mieghem, Roxana Mehran, Lars Søndergaard, et al

AutocathFFR System Outcomes Comparable to Wire-Based FFR

Hector M Garcia-Garcia,

USC Discussion: Hemodynamics in Cardiogenic Shock

Alexander G Truesdell, Jaime A Hernandez-Montfort, Varinder Kaur Randhawa, et al

UZ Clear Finds 50% Patients with Angina Have Evidence of CAD

Carlos Collet,

Bruno Scheller, Stefan Tunev, Darren Mylotte, et al

José M de la Torre Hernández, Tamara García Camarero, Aritz Gil Ongay, et al

Ep 4: The EXCEL Trial: The Interventionalists’ Perspective

George William Hunter,

Gregg Stone, Robert Kloner,

PARTNER 3: TAVR is Cost Effective Compared with SAVR for Low-Risk Patients

David J Cohen,

OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG

David Kandzari,

View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

View from the Thoraxcenter: AHA 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

What to Expect at Complex PCI 2021

Bill D Gogas, Duk-Woo Park,

TCT 2021: 12Mo Results Comparing PCB With SCB Show No Difference in Clinical Incidences

Wan Azman Wan Ahmad,

TCT 21: SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB

Bruno Scheller,

TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients

Susheel Kodali,

SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB

Rafael Romaguera,

iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR

Matthias Gotberg,

FAME3: PCI Guided by FFR Didn't Meet Noninferiority for 1Y Outcomes Compared to CABG

William Fearon,

View from the Thoraxcenter: TCT 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

Articles

OCT in MINOCA

Grigoris Karamasis

,

Iosif Xenogiannis

,

Charalampos Varlamos

,

Spyridon Deftereos

,

Dimitrios Alexopoulos

,

Published:

09 May 2022

Citation:

Interventional Cardiology 2022;17:e06.

DOI:

https://doi.org/10.15420/icr.2021.31
  • Views: Views 57
  • Downloads: Downloads 3

Best Practice in Intravascular Lithotripsy

Benjamin Honton

,

Jacques Monsegu

,

Published:

28 January 2022

Citation:

Interventional Cardiology 2022;17:e02.

DOI:

https://doi.org/10.15420/icr.2021.14
  • Views: Views 3737
  • Downloads: Downloads 155

Post-CABG Management of Occlusive CAD

Mohammed Shamim Rahman

,

Ruben de Winter

,

Alex Nap

,

Paul Knaapen

,

Published:

24 December 2021

Citation:

Interventional Cardiology 2021;16:e33.

DOI:

https://doi.org/10.15420/icr.2021.12
  • Views: Views 576
  • Downloads: Downloads 42

Management of Coronary Disease in TAVI Patients

Antonio FB de Azevedo Filho

,

Tarso AD Accorsi

,

Henrique B Ribeiro

,

Published:

07 December 2021

Citation:

European Cardiology Review 2021;16:e49.

DOI:

https://doi.org/10.15420/ecr.2021.27
  • Views: Views 533
  • Downloads: Downloads 53